Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Schmitz, N
[Clear All Filters]
2018
Hutchings M
,
Ladetto M
,
Buske C
,
P Brown deNully
,
Ferreri AJM
,
Pfreundschuh M
,
Schmitz N
,
A Balari S
,
van Imhoff G
,
Walewski J
.
ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.
Ann Oncol. 2018.
PubMed
Google Scholar
Maurer MJ
,
Habermann TM
,
Shi Q
,
Schmitz N
,
Cunningham D
,
Pfreundschuh M
,
Seymour JF
,
Jaeger U
,
Haioun C
,
Tilly H
, et al.
Progression-Free Survival at 24 Months (PFS24) and Subsequent Outcome For Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Enrolled On Randomized Clinical Trials.
Ann Oncol. 2018.
PubMed
Google Scholar
2016
Wilhelm M
,
Smetak M
,
Reimer P
,
Geissinger E
,
Ruediger T
,
Metzner B
,
Schmitz N
,
Engert A
,
Schaefer-Eckart K
,
Birkmann J
.
First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.
Blood Cancer J. 2016;6(7):e452.
PubMed
Google Scholar
Van Den Neste E
,
Schmitz N
,
Mounier N
,
Gill D
,
Linch D
,
Trneny M
,
Bouadballah R
,
Radford J
,
Bargetzi M
,
Ribrag V
, et al.
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
Bone Marrow Transplant. 2016.
PubMed
Google Scholar
2015
Ho AD
,
Schetelig J
,
Bochtler T
,
Schaich M
,
Schäfer-Eckart K
,
Hänel M
,
Rösler W
,
Einsele H
,
Kaufmann M
,
Serve H
, et al.
Allogeneic stem cell transplantation improves survival in patients with AML characterized by a high allelic ratio of mutant FLT3-ITD.
Biol Blood Marrow Transplant. 2015.
PubMed
Google Scholar
Van Den Neste E
,
Schmitz N
,
Mounier N
,
Gill D
,
Linch D
,
Trneny M
,
Milpied N
,
Radford J
,
Ketterer N
,
Shpilberg O
, et al.
Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.
Bone Marrow Transplant. 2015.
PubMed
Google Scholar